Xenova Group plc

Home
What is Brain Cancer?
About the Trial
Are You Eligible?
Participating Centre Locations
Useful Links
About Clinical Trials
FAQs
Glossary

Print Version

This Phase III clinical trial is for patients with non-operable, progressive and/or recurrent glioblastoma multiforme. To find out if you might be eligible to participate in this study, please review the inclusion and exclusion criteria outlined below. However, please contact a trial centre for more information about the trial and eligibility requirements, and discuss with your doctor before beginning any treatment.

INCLUSION CRITERIA INCLUDE (BUT ARE NOT LIMITED TO):
• Male or female at least 18 years of age
• Diagnosed GBM
• Progressive and/or recurrent GBM after conventional therapy
• Patient is not considered a candidate for surgery
Karnofsky Performance Score 70-100
• Tumour characteristic must be:
      • Unifocal
      • Unilateral
      • Lesion diameter equal to or greater than 1.0 cm and equal to or less than 4.0 cm

EXCLUSION CRITERIA INCLUDE (BUT ARE NOT LIMITED TO):
• Chemotherapy within 30 days prior to study entry, or nitrosoureas or
  Mitomycin-C therapy within 42 days prior to study entry
• Radiotherapy or stereotactic (gamma knife) radiosurgery within 90 days prior to
  study entry
• Tumour surgery, tumour debulking or other neurosurgery procedure within 30 days prior to study entry


 
© 2006 Xenova Ltd